Is Instil Bio, Inc. (TIL) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 144.4% / 30% | 188.4% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 144.4% / 33% | 188.4% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 33.0% / 33% | 43.0% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 144.4% / 33% | 188.4% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 33.0% / 33% | 43.0% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -50.6% | |
| Return on Assets (ROA) | -14.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$56M |
| Free Cash Flow | -$66M |
| Total Debt | $87M |
| Debt-to-Equity | 70.5 |
| Current Ratio | 34.5 |
| Total Assets | $264M |
Price & Trading
| Last Close | $8.36 |
| 50-Day MA | $8.10 |
| 200-Day MA | $17.13 |
| Avg Volume | 125K |
| Beta | 2.1 |
|
52-Week Range
$5.67
| |
About Instil Bio, Inc. (TIL)
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial for the treatment of patients with chemotherapy in patients with advanced/metastatic non-small cell lung cancer. The company also conducts a Phase 1 open label trial in China for AXN-2510/IMM2510 as monotherapy in patients with advanced solid tumors, including triple-negative breast cancer, squamous non-small cell lung cancer, hepatocellular carcinoma, renal cell carcinoma, and rare solid tumors, such as soft tissue sarcomas and thymic cancer. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Instil Bio, Inc. (TIL) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Instil Bio, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Instil Bio, Inc.'s debt ratio?
Instil Bio, Inc.'s debt ratio is 144.4% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 33.0%.
What are Instil Bio, Inc.'s key financial metrics?
Instil Bio, Inc. has a market capitalization of $53M. Return on equity stands at -50.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.